Angie M. Boyce, PhD, is Research Scholar and Associate Faculty, Berman Institute of Bioethics, Johns Hopkins University, Baltimore, MD.
Brian T. Garibaldi, MD, MEHP, is Director, Johns Hopkins Biocontainment Unit, and Associate Professor, Medicine and Physiology, Johns Hopkins University School of Medicine, Baltimore, MD.
Health Secur. 2019 Jan/Feb;17(1):62-68. doi: 10.1089/hs.2018.0108. Epub 2019 Feb 6.
Host genomic research on high-consequence infectious diseases is a growing area, but the ethical, legal, and social implications of such findings related to potential applications of the research have not yet been identified. While there is a robust ethical debate about the ethical, legal, and social implications of research during an emergency, there has been less consideration of issues facing research conducted outside of the scope of emergency response. Addressing the implications of research at an early stage (anticipatory ethics) helps define the issue space, facilitates preparedness, and promotes ethically and socially responsible practices. To lay the groundwork for more comprehensive anticipatory ethics work, this article provides a preliminary assessment of the state of the field with a scoping review of host genomic research on a subset of high-consequence infectious diseases of relevance to high-level isolation units, focusing on its ethically relevant features and identifying several ethical, legal, and social implications raised by the literature. We discuss the challenges of genomic studies of low-frequency, high-risk events and applications of the science, including identifying targets to guide the development of new therapeutics, improving vaccine development, finding biomarkers to predict disease outcome, and guiding decisions about repurposing existing drugs and genetic screening. Some ethical, legal, and social implications identified in the literature included the rise of systems biology and paradigm shifts in medical countermeasure development; controversies over repurposing of existing drugs; genetic privacy and discrimination; and benefit-sharing and global inequity as part of the broader ecosystem surrounding high-level isolation units. Future anticipatory ethics work should forecast the science and its applications; identify a more comprehensive list of ethical, legal, and social implications; and facilitate evaluation by multiple stakeholders to inform the integration of ethical concerns into high-level isolation unit policy and practice.
针对高后果传染病的宿主基因组研究是一个不断发展的领域,但尚未确定与该研究的潜在应用相关的发现的伦理、法律和社会影响。虽然在紧急情况下研究的伦理、法律和社会影响方面存在激烈的伦理争论,但对于紧急情况范围之外进行的研究所面临的问题考虑较少。在早期(前瞻性伦理)解决研究的影响有助于定义问题空间,促进准备工作,并促进符合伦理和社会责任的实践。为了为更全面的前瞻性伦理工作奠定基础,本文通过对与高水平隔离单位相关的一组高后果传染病的宿主基因组研究进行范围审查,对该领域进行了初步评估,重点关注其与伦理相关的特征,并确定了文献中提出的若干伦理、法律和社会影响。我们讨论了低频、高风险事件的基因组研究和科学应用的挑战,包括确定指导新疗法开发的目标、改进疫苗开发、寻找预测疾病结果的生物标志物以及指导现有药物和遗传筛选重新定位的决策。文献中确定的一些伦理、法律和社会影响包括系统生物学的兴起和医学对策开发范式的转变;重新定位现有药物的争议;遗传隐私和歧视;以及作为高水平隔离单位更广泛生态系统的一部分的利益共享和全球不平等。未来的前瞻性伦理工作应该预测科学及其应用;确定更全面的伦理、法律和社会影响清单;并促进多方利益相关者的评估,以便将伦理问题纳入高水平隔离单位的政策和实践。